---  
layout: startup_page  
title: "Halda Therapeutics"  
id: "haldatherapeutics.com"  
permalink: "/haldatherapeuticshaldatherapeutics.com08122024/"  
website: "https://haldatherapeutics.com/"  
funding_round: "Series B+"  
funding_amount: "$126M"  
investors: "Deep Track Capital, Frazier Life Sciences, RA Capital Management, Vida Ventures, Boxer Capital, Taiho Ventures, Canaan Partners, Access Biotechnology, Elm Street Ventures, Connecticut Innovations"  
about: "Halda Therapeutics is a biotechnology company developing RIPTAC™ (Regulated Induced Proximity TArgeting Chimeras) therapeutics, a novel class of cancer therapies designed to overcome drug resistance. Their lead program targets prostate and breast cancer, with a Phase 1 clinical trial expected to begin in the first half of 2025. The RIPTAC modality employs a \"hold and kill\" mechanism targeting specific proteins within cancer cells."  
markets: "Biotechnology, Oncology, Cancer Therapeutics"  
hq: "New Haven, Connecticut, United States"  
founded_year: "2018"  
linkedin: "https://www.linkedin.com/company/halda-therapeutics/"  
twitter: "https://twitter.com/HaldaThera"  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/halda-therapeutics"  
pitchbook: "https://pitchbook.com/profiles/company/266625-91"  

date_display: "12-Aug-2024"  
date: "2024-08-12"

# SEO Optimization  
meta_title: "Halda Therapeutics - Series B+ Funding ($126M)"  
meta_description: "Halda Therapeutics, Halda Therapeutics is a biotechnology company developing RIPTAC™ (Regulated Induced Proximity TArgeting Chimeras) therapeutics, a novel class of cance..."  
meta_keywords: "Halda Therapeutics, Biotechnology, Oncology, Cancer Therapeutics, Series B+ funding"  
canonical_url: "https://startup.projectstartups.com/haldatherapeuticshaldatherapeutics.com08122024/"  
---